Released on:
November 19, 2025
Expires on:
November 19, 2026
Target Audience
This activity has been designed to meet the educational needs of neurology clinicians (MDs, DOs, NPs, PAs, nurses, pharmacists) and other members of the healthcare team involved in the management of patients with MS.
Learning Objectives
Upon completing this activity, participants should be better able to:
- Describe the latest safety and efficacy findings and patient-reported outcomes (PROs) with B-cell depleting therapies (BCDTs), including anti-CD20 monoclonal antibodies, for MS
- Evaluate the most recent clinical evidence on emerging BCDTs for MS, such as BTK inhibitors
- Individualize treatment selection for people with MS based on the latest data, PROs, MS
Faculty
Anne Cross, MD, FAAN
Professor of Neurology
The Manny & Rosalyn Rosenthal – Dr. John L. Trotter MS Center Chair in Neuroimmunology of Barnes-Jewish Hospital
Section Head, MS & Neuroimmunology Section
Washington University School of Medicine
Christine Marcello, MSN, FNP-BC, MSCN
Family Nurse Practitioner
Multiple Sclerosis Certified Nurse
Thomas Jefferson University Hospital
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The Consortium of Multiple Sclerosis Centers designates this enduring material for 0.5 nursing continuing professional development (NCPD) credit (0.5 in the area of pharmacology).
Pharmacists
This knowledge-based activity (UAN JA4008165-9999-25-018-H01-P) qualifies for 0.5 contact hours (.05 CEUs) of continuing pharmacy education credit.
Physician Assistants (PAs)
The Consortium of Multiple Sclerosis Centers has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid November 19, 2027. PAs should only claim credit commensurate with the extent of their participation.
Statement of Participation for Other Healthcare Professionals
All other health care professionals completing this course will be issued a statement of participation.
Disclosure of Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC requires that individuals in a position to control the content of an accredited continuing education activity disclose all financial relationships with any ineligible company within the past 24 months. It is the policy of the CMSC to mitigate all relevant financial disclosures from planners, faculty, and other persons that can affect the content of this CE activity. CMSC seeks to ensure independence, objectivity, balance, and scientific rigor in all educational programs and to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC is committed to providing learners with high-quality CE activities that promote improvements in healthcare and not those of an ineligible company. For this activity, all relevant financial relationships have been mitigated.
Faculty Disclosures
Anne Cross, MD, FAAN has disclosed the following relevant financial relationships: Consultant, Advisor: EMD Serono, Novartis, Genentech. Contracted Research: EMD Serono, Moderna, Genentech. Consultant: Biogen, TG Therapeutics, Janssen (J&J), Horizon, Bristo Myers Squibb. Scientific Advisory Board: Roche
Christine Marcello, MSN, FNP-BC, MSCN has disclosed the following relevant financial relationships: APRN Advisory Board Speaker: Sanofi, Genentech
All of the relevant financial relationships listed for these individuals have been mitigated.
Staff Disclosures
Laurie Scudder, DNP, NP, served as planner and reviewer and has disclosed no relevant financial relationships.
Kathleen Costello, MS, CRNP, MSCN, served as planner and reviewer and has disclosed no relevant financial relationships.
All other staff of the CMSC who are in a position to control content have disclosed no relevant financial relationships
Method of Participation / How to Receive Credit
To successfully complete this activity, the participant must go to www.Medlive.com. To receive credit, participants must (1) read the activity front matter, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive credit, participants must receive a minimum score of 70% on the post-test
Disclosure of Off-Label Use
CMSC and MedliveCME (require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Commercial Support Acknowledgment
This activity is supported by an educational grant received from Novartis Pharmaceuticals and TG Therapeutics, Inc.
Disclaimer
CMSC and MedliveCME present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC and MedliveCME, and the commercial supporter(s) assume no liability for the information herein.
Privacy Policy
Please review our privacy policy here: https://www.medlive.com/privacy-policy
Contact Information
If you have any questions about this activity, please contact the Medlive at 877-394-1306 or at [email protected].